Search results
Results from the WOW.Com Content Network
Abdominal CT shows a 7.1 × 4.3 × 5.4 cm septal cystic, solid mass was detected on the left adnexal, and the solid components were enhanced. Specialty: Gynaecology: Symptoms: Pain of the pelvic / illiac regions especially if it involves the ovaries or fallopian tubes: Types: Benign or malignant; simple or complex
Serous cystadenocarcinoma is a serous tumor in the cystadenocarcinoma grouping.. Most commonly, the primary site of serous cystadenocarcinoma is the ovary.Rare occurrence in the pancreas has been reported, although this is not typical, with the majority of microcystic pancreatic masses representing alternate disease processes such as the more benign serous cystadenoma.
These ovarian tumors are usually multi-septated, cystic masses with thin walls. They also contain varying amounts of solid tissue which consists of proliferating stromal tissue, papillae, or malignant tumor cells. Benign mucinous cystadenomas compose 80% of mucinous ovarian tumors [2] and 20–25% of benign ovarian tumors overall. The peak ...
Cystadenocarcinoma is a malignant form of a cystadenoma and is a cancer derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur.
The five-year survival rate for all stages of ovarian cancer is 46%; the one-year survival rate is 72% and the ten-year survival rate is 35%. [131] For cases where a diagnosis is made early in the disease, when the cancer is still confined to the primary site, the five-year survival rate is 92.7%. [ 132 ]
An ovarian cyst is a fluid-filled sac within the ovary. [1] They usually cause no symptoms, [ 1 ] but occasionally they may produce bloating, lower abdominal pain, or lower back pain. [ 1 ] The majority of cysts are harmless.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Prognosis again is dependent on the spread of the tumor, as well as how differentiated the tumor appears. The overall prognosis is somewhat worse than for serous or mucinous tumors, and the 5-year survival rate for patients with tumors confined to the ovary is approximately 75%.